Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Google Inc (GOOG): Is All This Trouble Worth $200K?

While the policy changes that Google Inc (NASDAQ:GOOG) implemented last year “simplified and standardized” across all devices and all Google services, there were still critics who claimed that Google did not provide an opt-out option for users other than not signing into any Google platform. And that  was seen to be a violation of EU law, which allows for choices by consumers and competition for consumers. Without this opt-out ability, the critics said, Google then had free reign to gather untold amounts of data on users across the entire Internet and can have discretion on how long to store and keep the information. What do you think about this? Is going through the trouble of changing the policies again worth $200,000? What about the PR hit the company can take if it does nto comply? Is that worth the money Google would pay out? Give us your feedback in the comments section elow.

DISCLOSURE: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.